Professional Documents
Culture Documents
Mary Mercurio
Background
Breast cancer is the most common cancer in women independent of race or ethnicity.
In 2018, an estimated 266,120 new cases of invasive breast cancer are expected to be
diagnosed in women in the U.S., along with 63,960 new cases of non-invasive breast cancer.
About 40,920 women in the U.S. are expected to die in 2018 from breast cancer. Death rates
have been decreasing since 1989. Women under the age of 50 have experienced larger
decreases. As of January 2018 there are more than 3.1 million women with a history of breast
cancer. This includes women currently being treated and women who have finished treatment
A Woman’s risk for breast cancer nearly doubles if she has a first degree relative who
has been diagnosed with breast cancer. Less than 15% of women who get breast cancer have a
family member diagnosed with it. 5-10% of breast cancers can be linked to gene mutations
inherited from one’s parent. Mutation of the BRCA1 and BRCA2 genes are the most common.
On average women with the BRCA1 mutation have a 55% lifetime risk of developing breast
cancer and for women with the BRCA2 mutation have a 45% risk. Those who test positive for
BRCA1 or BRCA2 mutation tend to develop breast cancer more often in women of younger age.
Approximately 85% of breast cancers occur in women who have no family history (US Breast
While guidelines for breast cancer screening in average risk patients are well
established, screening in high risk women is not as clear. For patients with BRCA1 and BRCA2
mammography starting at age 30. For some high risk patients additional screening with MRI is
encouraged. While mammography is the only imaging modality proven to reduce mortality
from breast cancer an MRI can identify smaller malignancies at a greater resolution at an earlier
stage. MRI use would be more cost effective as there would be less need for invasive
Management of women who are considered high risk for breast cancer is controversial.
This is because mammography alone has its limitations in screening younger women with more
dense breast tissue or with specific tumor phenotypes. For women with BRCA1 or BRCA2
mutations current guidelines recommend starting with MRI at age 25 and then adding
Most practitioners will screen women with annual MRI if they have a calculated
increased risk. Risk is calculated every year to determine who still needs annual MRI using a risk
model. One model used to calculate the risk for breast cancer is the Gail model which is used in
women with no history of breast cancer, another model is the Breast Cancer Consortium (BCCS)
Prevention and Early Detection of Breast Cancer 4
calculator or a new model called the Tyrer-Cuzick model which is the most consistently accurate
PICOT Question
To further understand how to prevent and detect breast cancer early in high risk
patients to have a better outcome. The PICOT question for this research paper focuses on:
What tools and resources are available for nurses and other medical staff to help high risk
patients know their risk and what to do about preventing and detecting breast cancer early?
For the purpose of this paper, “high risk” patients encompasses all women that have a
strong family history of breast cancer and those who have a positive BRCA 1 or BRCA 2 gene
Diagnosis Question
The PICOT question being addressed in this paper is an Assessment type of question.
The type of question that will look at how best to assess how high the risk is, and how to best
prevent and detect breast cancer early for a better outcome when making decisions on what to
Evidence
The assessment type of question in this research is best answered by evidence that
focuses on development of tools for assessing, preventing, and detecting breast cancer early in
those who are at a higher risk for it. In this case, research articles focusing on tools for
assessment, prevention and early detection would be the most appropriate evidence to use in
Databases
The databases used for this paper were CINAHL, PUBMED, PMC US National library of
Medicine, The American Cancer Society, and Breast Cancer. Org. In my original search for
“prevention and early detection of breast cancer in high risk patients” it was a very broad topic
with 766,000 results. Changing the search to “prevention of breast cancer” and “detection of
breast cancer” helped narrow the articles down to more specific current and relevant articles.
Research Methods
Of the articles I used for this paper, two were statistical articles of the risk for detecting
breast cancer, three were full text descriptive articles of different assessment tools used in
Prevention and Early Detection of Breast Cancer 6
detecting breast cancer and the others were focused on screening and prevention. One clinical
trial, and the rest of the articles were descriptive journals from experts in the breast cancer
research field.
Level of Evidence
Based on the amount of research found on this subject, the level of evidence for the
PICOT question is high. There are many well-written articles, journals, and statistical findings.
While breast cancer research is ongoing and they are always coming up with new evidence
there is always a need for more research. There are still many articles and journals that are very
beneficial in helping a patient determine what is considered high risk and what screening is best
for each patient. I do feel that more research can always be done. I hope more research will be
done in the areas of prevention including a healthy diet, regular exercise and healthy living in
general to help in decreasing the risk of breast cancer, and to support this portion of the PICOT
Summary of Findings
Most of the articles I found for this PICOT question were very well written and had very
similar findings in correlation to the prevention and early detection of breast cancer in high risk
patients. It is not surprising finding all the research that has been done to help in preventing
and decrease the risk of breast cancer, as it is the most common cancer in women.
Prevention and Early Detection of Breast Cancer 7
Primary prevention involves health promotion and risk reduction in the general
population so that invasive cancers do not develop. Primary preventive measures include life
style changes such as smoking cessation, diet modifications, and vitamin supplements,
screening tools as ways of detection. Avoiding risk factors can lead to decreased morbidity and
premalignant and subclinical cancers by means of mammography and MRI (Fisher, 2017).
Dietary Prevention of breast cancer consists of a low fat diet. There are indications that
breast cancer risk is increased with food consumption that is rich in fat and low in fiber. It has
been reported that dietary fat and post-menopausal estrogen levels are directly related. Low
fat and high carbohydrate foods lead to significant reduction in breast density. Lifestyle factors
which may affect breast cancer risk include sexual behavior pattern, alcohol intake, physical
activity and obesity. Epidemiologic data indicates that obesity increases the risk of breast
Prophylactic Mastectomy is also a preventative strategy for those with a high risk that
are influenced by a range of factors as well as women who carry the mutation BRCA1 or BRCA2.
informed about the effectiveness along with possible morbidities of this procedure in
association with cancer risk assessment and other preventative strategies (Hartman, 1999).
Prevention and Early Detection of Breast Cancer 8
Finding breast cancer and getting state of the art cancer treatment are the most
important strategies to prevent deaths from breast cancer. Breast cancers that are found early
when small and have not spread are easier to treat successfully. Getting regular screening tests
is the most reliable way to detect breast cancer early. Doing self-breast exams and having
clinical breast exams are recommended, but studies have shown little evidence that doing self-
breast exams and having clinical breast exam help in find breast cancer early with women who
get regular screening mammograms (Huang, 1997). Overall, early detection and prevention of
breast cancer in high risk patients is a large ongoing issue. Nurses and other trained medical
staff should be aware of risk assessment tools to help patients identify their risk as well as
getting the proper testing to see if they may carry the gene mutations of breast cancer, staff
should also encourage routine screening to help in the early detection and prevention of breast
cancer. Nurses should be able to help in the education of preventative strategies to assist in the
The clinical implications for prevention and early detection of breast cancer of high risk
significant as the best therapy is prevention. Detecting breast cancer early is how to have the
best prognosis, as treatment of breast cancer at an early stage will provide for maximum
Prevention and Early Detection of Breast Cancer 9
chance of survival. Breast cancer screening has a well-established role in the early detection of
Myself (as a nurse) along with Doctors and other medical staff need help in continuing
to provide education to patients regarding the risk of breast cancer and prevention of it. We
need to encourage routine screenings along with yearly risk assessments to help in determining
the level of risk of patients so that they can be aware and get the proper screenings and
treatments for a better outcome. Providing patients with information on where to go for
routine testing and educating them on the importance of prevention and early detection is
crucial.
If I were given the opportunity I would focus on the education aspect so that I could
inform patients about prevention. I would educate them about a healthy lifestyle, and give
them resources so they would be aware of things to avoid doing and eating to give them a
better chance at lowering the risk for breast cancer. I would like to make sure patients that are
high risk know what options they have and what testing is out there that can be done. This
would allow them to know what their risk is and how having these tests done as recommended
by the guidelines provided by the different assessment tools available can lead them to a better
References
Fisher, B. A.; Wilkinson, L; Valencia, A. (2017) Women’s interest in a personal breast cancer risk
assessment and lifestyle advice at NHS mammography screening. March2017;
39(1):113-121. (9p)
Cass, Ilana. (2017) Advances in breast cancer screening and prevention: New technologies offer
ob/gyns more tools to identify and treat patients at risk. Dec2017; v.62n.12, 7-14. (3p)
Murray T, Bolden S, Wingo PA. Cancer Statistics 2000. CA Cancer J Clin. 2015; 50: 7–14
Greenwald, Peter. Cancer Prevention Clinical Trials. J Clin Oncol. 2012; 20: 14–22.
U.S. Breast Cancer Statistics. (n.d.). Retrieved April 7, 2018 from
http://www.breastcancer.org/symptoms/understand_bc/statistic
American Cancer Society Recommendations for the Early Detection of Breast Cancer. (n.d.).
Retrieved April 7, 2018, from https://www.cancer.org/cancer/breast-cancer/screening-tests-
and-early-detection/american-cancer-society-recommendations-for-the-ealy-detection-of-
breast-cancer.html#references
Hunter DJ, Spiegelman D, Adami HO, et al. Cohort studies of fat intake and the risk of breast
cancer- A pooled analysis. N Engl J Med. 1996; 334:356-61
Boyd NF, Greenberg C, Lockwood GA, et al. Effect of a low -fat, high carbohydrate diet on
radiologic features of the breast. J Natl Cancer Inst. 1997; 89:488–96.
Thune I, Brenn T, Lund E, et al. Physical activity and the risk of breast cancer. N Engl J
Med. 1997; 336:1269–75.
Ferraroni M, Decarli A, Franceschi S, et al. Alcohol consumption and breast cancer. European
Journal of Cancer. 1998; 34:1403–9.
Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast
cancer risk. JAMA. 1997; 278:1407–11.
Hartman LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women
with a family history of breast cancer. N Engl J Med. 1999; 340:77–84.